Funding for this research was provided by:
Vergent Bioscience, Inc.
Received: 7 May 2020
Accepted: 13 August 2020
First Online: 29 September 2020
Ethics approval and consent to participate
: All applicable national and institutional guidelines for the care and use of animals were followed. Animal experiments were approved by the Institutional Animal Care and Use Committee of the University of Groningen and performed according to Dutch law.
: Not applicable.
: G.M.V.D. is a consultant for Vergent Bioscience, member of the Scientific Advisory Board of SurgVision B.V, CEO, founder and share-holder of TRACER Europe B.V. M.B. is a consultant for Vergent Bioscience, and J.S. and E.B. are employees of Vergent Bioscience. The remaining authors declare no conflict of interest related to this study.